Skip to content

Copyright in Medical Communications: Rightsholders Survey

To help us better understand your experience with MedComm related licensing needs and challenges, emerging use cases, and inform future industry insights, kindly complete the brief survey below. All responses will remain anonymous and are for CCC's internal use only. Thank you.
1.Regarding commercial reuse of copyrighted material by pharmaceutical and MedComm buyers, please rate the anticipated demand for the following over the next 12 months:
Increased
No change
Decreased
Permissions needed for reuse of copyrighted content
Reuse of Open Access (specifically CCBY) content
Reuse of AI-generated content, including summaries
Bundled licensing and pricing options that cover multiple reuse needs
Discounted volume pricing
2.Do you receive requests from Pharma/MedComms professionals seeking permission to use AI tools to create any of the following? Check all that apply.
3.Has the size of your in-house permissions team changed in the last 12 months?
4.Has the size of your in-house reprints team changed in the last 12 months?
5.What common questions do you receive from Pharma/MedComms buyers regarding content licensing?